Contralateral breast cancer risk in BRCA1/2-positive families needs to be adjusted for phenocopy rates particularly in second-degree untested relatives

Benzer Materyaller

• Can multiple SNP testing in BRCA2 and BRCA1 female carriers be used to improve risk prediction models in conjunction with clinical assessment?
  Yazar:: Prosperi, Mattia CF, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Are BRCA1- and BRCA2-related breast cancers associated with increased mortality?
  Yazar:: Gareth Evans, D, ve diğerleri
  Baskı/Yayın Bilgisi: (2004)
• Risks of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
  Yazar:: Ahmed, M, ve diğerleri
  Baskı/Yayın Bilgisi: (2010)
• BRCA phenocopies or ascertainment bias?
  Yazar:: Goldgar, David, ve diğerleri
  Baskı/Yayın Bilgisi: (2007)
• Genetic variants of prospectively demonstrated phenocopies in BRCA1/2 kindreds
  Yazar:: Dominguez-Valentin, Mev, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)